ACGT Blog.
ACGT Luncheon at SITC 2026: 25 Years of Cancer Cell and Gene Therapy
At SITC 2026, ACGT’s annual lunch symposium brought together the cancer cell and gene therapy community together annually to consider the latest advances and challenges faced by the field with a particular focus on hard-to-treat cancers like those of the brain, pancreas, and ovary.
Read MoreACGT Luncheon at SITC 2026: 25 Years of Cancer Cell and Gene Therapy
At SITC 2026, ACGT’s annual lunch symposium brought together the cancer cell and gene therapy community together annually to consider the latest advances and challenges faced by the field with a particular focus on hard-to-treat cancers like those of the brain, pancreas, and ovary.
Read MoreACGT at SITC 2026: Preview
The Society for Immunotherapy of Cancer (SITC) holds its 41st Annual Meeting & Pre-Conference Programs November 4–8 in Phoenix, and ACGT hosts our annual SITC Lunch Symposium on November 6.
Read MoreACGT at SITC 2026: Preview
The Society for Immunotherapy of Cancer (SITC) holds its 41st Annual Meeting & Pre-Conference Programs November 4–8 in Phoenix, and ACGT hosts our annual SITC Lunch Symposium on November 6.
Read MoreFrom Breakthrough Science to Patient Impact: ACGT Joins Conversations Shaping the Future of Cancer Therapy
How do we turn a promising scientific discovery into a cancer therapy that can change and potentially save patients’ lives?
Read MoreFrom Breakthrough Science to Patient Impact: ACGT Joins Conversations Shaping the Future of Cancer Therapy
How do we turn a promising scientific discovery into a cancer therapy that can change and potentially save patients’ lives?
Read MoreTIL: The Original Cell Therapy for Cancer
Long before CAR T cells, tumor-infiltrating lymphocyte (TIL) therapy was in clinical trials at the National Cancer Institute in the 1980s.
Read MoreTIL: The Original Cell Therapy for Cancer
Long before CAR T cells, tumor-infiltrating lymphocyte (TIL) therapy was in clinical trials at the National Cancer Institute in the 1980s.
Read MoreACGT Gala Celebrates 25 Years.
On Thursday, October 1, 2026, Alliance for Cancer Gene Therapy (ACGT) marked 25 years of championing cancer cell and gene therapy research.
Read MoreACGT Gala Celebrates 25 Years.
On Thursday, October 1, 2026, Alliance for Cancer Gene Therapy (ACGT) marked 25 years of championing cancer cell and gene therapy research.
Read More"A Bad Day for Cancer, a Good Day for Hope."
In June, Swim Across America – Fairfield County celebrated 20 years of support for ACGT
Read More"A Bad Day for Cancer, a Good Day for Hope."
In June, Swim Across America – Fairfield County celebrated 20 years of support for ACGT
Read MoreReimagining Cell and Gene Therapy for Brain Tumors
Glioblastoma has long been one of oncology’s toughest challenges, with survival improving only incrementally despite advances in surgery, radiation, and chemotherapy.
Read MoreReimagining Cell and Gene Therapy for Brain Tumors
Glioblastoma has long been one of oncology’s toughest challenges, with survival improving only incrementally despite advances in surgery, radiation, and chemotherapy.
Read MoreSolving Sarcoma with Dr. Stephen Gottschalk
For Sarcoma Awareness Month, we spoke with Dr. Stephen Gottschalk to learn about the latest clinical advances for these rare cancers.
Read MoreSolving Sarcoma with Dr. Stephen Gottschalk
For Sarcoma Awareness Month, we spoke with Dr. Stephen Gottschalk to learn about the latest clinical advances for these rare cancers.
Read MoreASCO 2026: Advances in Pancreatic Cancer, Glioblastoma, and More
ASCO 2026 revealed promising advances in hard-to-treat pancreatic and brain cancers, including with CAR T cells and personalized vaccines.
Read MoreASCO 2026: Advances in Pancreatic Cancer, Glioblastoma, and More
ASCO 2026 revealed promising advances in hard-to-treat pancreatic and brain cancers, including with CAR T cells and personalized vaccines.
Read MoreACGT Summit 2026: 25 Years of Cancer Cell and Gene Therapy
At ACGT Summit 2026, the leading scientists, clinicians, and industry experts in cancer cell and gene therapy came together to celebrate how far the field has come—and to chart what’s next.
Read MoreACGT Summit 2026: 25 Years of Cancer Cell and Gene Therapy
At ACGT Summit 2026, the leading scientists, clinicians, and industry experts in cancer cell and gene therapy came together to celebrate how far the field has come—and to chart what’s next.
Read MoreACGT hosts lunch symposium, SAC members honored at SITC 2025.
ACGT had a strong presence at this year’s SITC 2025 Annual Meeting in National Harbor, Maryland, hosting a Lunch Symposium that brought together leading experts in cancer cell and gene therapy to connect and share knowledge and insights.
Read MoreACGT hosts lunch symposium, SAC members honored at SITC 2025.
ACGT had a strong presence at this year’s SITC 2025 Annual Meeting in National Harbor, Maryland, hosting a Lunch Symposium that brought together leading experts in cancer cell and gene therapy to connect and share knowledge and insights.
Read More19th annual SAA-FC open water swim raises more than $400K for ACGT
Close to 230 swimmers hit the water on June 21 in Stamford, Conn., for the annual Swim Across America – Fairfield County open water swim, which benefited ACGT for the 19th consecutive year.
Read More19th annual SAA-FC open water swim raises more than $400K for ACGT
Close to 230 swimmers hit the water on June 21 in Stamford, Conn., for the annual Swim Across America – Fairfield County open water swim, which benefited ACGT for the 19th consecutive year.
Read MoreFDA convenes roundtable on cell and gene therapy.
On June 5th, FDA held a cell and gene therapy roundtable discussing rare disease and cancer therapies and the opportunity to consider product development from the patient and family point of view. Leading experts, including ACGT Scientific Advisory Council members and Research Fellows Dr Crystal Mackall and Dr Carl June, were invited to share with FDA the progress and challenges and, most importantly, the incredible potential in curing diseases through cell and gene therapies.
Read MoreFDA convenes roundtable on cell and gene therapy.
On June 5th, FDA held a cell and gene therapy roundtable discussing rare disease and cancer therapies and the opportunity to consider product development from the patient and family point of view. Leading experts, including ACGT Scientific Advisory Council members and Research Fellows Dr Crystal Mackall and Dr Carl June, were invited to share with FDA the progress and challenges and, most importantly, the incredible potential in curing diseases through cell and gene therapies.
Read More












